Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 50045720
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078360(CHEMBL3414728)
Affinity DataEC50:  30nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078362(CHEMBL3414718)
Affinity DataEC50:  36nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078364(CHEMBL3414720)
Affinity DataEC50:  20nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078362(CHEMBL3414718)
Affinity DataEC50:  6.70E+3nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078364(CHEMBL3414720)
Affinity DataEC50:  1.40E+3nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078359(CHEMBL3414729)
Affinity DataEC50:  49nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078354(CHEMBL3414727)
Affinity DataEC50:  54nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078355(CHEMBL3414726)
Affinity DataEC50:  59nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078356(CHEMBL3414725)
Affinity DataEC50:  34nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078357(CHEMBL3414724)
Affinity DataEC50:  45nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078358(CHEMBL3414723)
Affinity DataEC50:  70nMAssay Description:Inhibition of XIAP BIR2-3 (124 to 356 residues) C202A/C213G mutant (unknown origin) in human THP1 cells using fluoresceinated caspase-3 substrate by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078359(CHEMBL3414729)
Affinity DataIC50: 3nMAssay Description:Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078360(CHEMBL3414728)
Affinity DataIC50: 5nMAssay Description:Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078354(CHEMBL3414727)
Affinity DataIC50: 7nMAssay Description:Inhibition of cIAP1 BIR2-3 (154 to 352 residues) (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078358(CHEMBL3414723)
Affinity DataIC50: 8nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078359(CHEMBL3414729)
Affinity DataIC50: 9nMAssay Description:Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarizat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078359(CHEMBL3414729)
Affinity DataIC50: 10nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078357(CHEMBL3414724)
Affinity DataIC50: 11nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078360(CHEMBL3414728)
Affinity DataIC50: 16nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078355(CHEMBL3414726)
Affinity DataIC50: 17nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078356(CHEMBL3414725)
Affinity DataIC50: 17nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078360(CHEMBL3414728)
Affinity DataIC50: 22nMAssay Description:Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarizat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078354(CHEMBL3414727)
Affinity DataIC50: 24nMAssay Description:Inhibition of cIAP1 BIR3 (154 to 352 residues) (unknown origin) by fluoresceinated dimeric SMAC peptide based fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078354(CHEMBL3414727)
Affinity DataIC50: 24nMAssay Description:Inhibition of XIAP BIR2-3 (125 to 356 residues) C202A/C213G mutant (unknown origin) fluoresceinated dimeric SMAC peptide based fluorescence polarizat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078356(CHEMBL3414725)
Affinity DataIC50: 29nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078360(CHEMBL3414728)
Affinity DataIC50: 36nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078355(CHEMBL3414726)
Affinity DataIC50: 40nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078358(CHEMBL3414723)
Affinity DataIC50: 47nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078354(CHEMBL3414727)
Affinity DataIC50: 54nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078359(CHEMBL3414729)
Affinity DataIC50: 65nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078357(CHEMBL3414724)
Affinity DataIC50: 68nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078362(CHEMBL3414718)
Affinity DataIC50: 110nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078364(CHEMBL3414720)
Affinity DataIC50: 160nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078361(CHEMBL3414575)
Affinity DataIC50: 180nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078366(CHEMBL3414722)
Affinity DataIC50: 214nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078363(CHEMBL3414719)
Affinity DataIC50: 232nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078365(CHEMBL3414721)
Affinity DataIC50: 235nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078371(CHEMBL3414716)
Affinity DataIC50: 366nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078370(CHEMBL3414715)
Affinity DataIC50: 900nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078367(CHEMBL3414712)
Affinity DataIC50: 1.32E+3nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078369(CHEMBL3414714)
Affinity DataIC50: 1.36E+3nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078368(CHEMBL3414713)
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 3(Human)
Ensemble Therapeutics

Curated by ChEMBL
LigandPNGBDBM50078372(CHEMBL3414717)
Affinity DataIC50: 2.88E+3nMAssay Description:Inhibition of XIAP BIR3 (241 to 356 residues) (unknown origin) incubated for 60 mins by fluoresceinated modified SMAC peptide based fluorescence pola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2016
Entry Details Article
PubMed